Status:
UNKNOWN
Pediatric Multicenter Study of REPEL-CV
Lead Sponsor:
SyntheMed
Conditions:
Adhesions
Eligibility:
All Genders
1-1 years
Phase:
PHASE2
Brief Summary
This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.
Detailed Description
\- Efficacy at second sternotomy
Eligibility Criteria
Inclusion
- Stage sternotomies
Exclusion
- Delayed closure beyond 5 days
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00116233
Last Update
June 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SyntheMed
Little Silver, New Jersey, United States, 07739